BiotechTV | All Videos

Kura Oncology's CEO gives an update on Q3 earnings day

Nov 2, 2023

Company News

Kura Oncology's CEO gives an update on Q3 earnings day

Troy Wilson describes the science behind Kura's menin inhibitor and farnesyl transferase inhibitor programs.

Dr. Eric Topol on the latest advances in medicine

Nov 1, 2023

Bright Minds

Dr. Eric Topol on the latest advances in medicine

Dr. Topol discusses the latest in COVID, GLP-1s, NASH, CRISPR, and AI in medicine.

Antibody oligonucleotide conjugates as an RNA strategy with the CEO of Avidity Biosciences

Nov 1, 2023

Bright Minds

Antibody oligonucleotide conjugates as an RNA strategy with the CEO of Avidity Biosciences

Sarah Boyce explains the rationale for using AOCs against muscle disorders like Myotonic dystrophy type 1 and DMD.

Talking allo CAR-T and seeing how it is manufactured at Poseida

Oct 31, 2023

Tech + Tours

Talking allo CAR-T and seeing how it is manufactured at Poseida

Kristin Yarema, CEO starting Jan 1st, describes Poseida's approach to allo CAR-T and then CMC expert Chad Headlee gives us a tour.

Breakfast at biolabs: Dallas Regional Chamber

Oct 26, 2023

Bright Minds

Breakfast at biolabs: Dallas Regional Chamber

Kelly Cloud describes the assets, infrastructure, and incentives that the Dallas area offers life sciences companies.

Oct 26, 2023

Bright Minds

Breakfast at biolabs: BioNTX

BioNTX CEO Kathleen Otto gives us a summary of the biotech activity in North Texas.

Stifel Analyst Alex Thompson joins BiotechTV for Analyst Thursdays

Oct 26, 2023

Bright Minds

Stifel Analyst Alex Thompson joins BiotechTV for Analyst Thursdays

Alex Thompson gives a deep dive into the I&I space and discusses Apogee, Aeglea, argenx, Immunovant, Aclaris, Morphic, and Ventyx.

Oct 26, 2023

Bright Minds

Breakfast at biolabs: GenrAb

Larry Tiffany describes how GenrAb is leveraging neurodegenerative stress and immunoogenetic models from UTSW for antibody discovery.

Oct 26, 2023

Bright Minds

Breakfast at biolabs: OncoNano Medicine

Marty Driscoll describes how OncoNano is utilizing a tumor's acidic environment to develop therapies and imaging agents.

Breakfast at biolabs: Secretome Therapeutics

Oct 26, 2023

Bright Minds

Breakfast at biolabs: Secretome Therapeutics

Vinny Jindal describes Secretome's approach to using neonatal cardiac progenitor cells.

Everything you need to know about lipid nanoparticle delivery with UTSW's Dan Siegwart

Oct 25, 2023

Bright Minds

Everything you need to know about lipid nanoparticle delivery with UTSW's Dan Siegwart

Dan Siegwart describes what goes into getting LNPs to places in the body beyond the liver, and how he has co-founded ReCode Therapeutics.

Form Bio's Chief Strategy Officer on optimizing the payload of cell and gene therapies

Oct 25, 2023

Bright Minds

Form Bio's Chief Strategy Officer on optimizing the payload of cell and gene therapies

Claire Aldridge explains how Form Bio was derived from the work that Colossal Bio was doing in Texas.

The Co-CEO of Renibus Therapeutics shares a company's perspective of the N. Texas biotech ecosystem

Oct 25, 2023

Company News

The Co-CEO of Renibus Therapeutics shares a company's perspective of the N. Texas biotech ecosystem

Jeff Keyser tells us about trying to help patients recover from surgeries more efficiently and the phase 2 data that led to Renibus' BTD.

UTSW's Eric Olson on using gene therapies and regenerative medicine for muscle disorders

Oct 25, 2023

Bright Minds

UTSW's Eric Olson on using gene therapies and regenerative medicine for muscle disorders

Dr. Olson describes work that has come out of his lab that aims to help diseases such as muscular dystrophy and hypertrophic cardiomyopathy.

UTSW's David Greenberg talks about trying to solve the problem of implant infections

Oct 24, 2023

Bright Minds

UTSW's David Greenberg talks about trying to solve the problem of implant infections

David Greenberg describes Solenic Medical's non-pharmaceutical solution to implant infections.

LH Capital’s Nicole Small gives an overview of the Dallas area biotech ecosystem

Oct 24, 2023

Bright Minds

LH Capital’s Nicole Small gives an overview of the Dallas area biotech ecosystem

Nicole Small describes the investments in infrastructure that are being made to grow entrepreneurs’ ability to keep science at home in DFW.

How MIT innovates with the Director of MIT’s Institute for Medical Engineering and Science

Oct 23, 2023

Bright Minds

How MIT innovates with the Director of MIT’s Institute for Medical Engineering and Science

Elazer Edelman explains how MIT acts as a bridge between the development of technology and the introduction of technology.

A deep dive into the oncology target PRMT5 with the CEO of Tango Therapeutics

Oct 20, 2023

Company News

A deep dive into the oncology target PRMT5 with the CEO of Tango Therapeutics

Barbara Weber walks us through the science of PRMT5, shares her reaction to recent data, and describes how programs are designed differently

The CEO of Kano Therapeutics discusses circular single-stranded DNA, and life as a startup

Oct 20, 2023

Bright Minds

The CEO of Kano Therapeutics discusses circular single-stranded DNA, and life as a startup

Floris Engelhardt describes how Kano is trying to use circular single-stranded DNA to correct gene length stretches of the genome.

The CEO of GreenLight Biosciences talks about using RNA in agriculture

Oct 19, 2023

Bright Minds

The CEO of GreenLight Biosciences talks about using RNA in agriculture

Andrey Zarur says that GreenLight is the largest manufacturer of RNA in the wold.

Follow BiotechTV

Sponsors

Sponsor Spotlight

Get in Touch

Advertise:

News coverage opportunities:

Contributors

Advertise@BiotechTV.com

MediaOppty@BiotechTV.com

Ali Gorman

Philadelphia Area

Brian Orelli

San Diego Area

General equiries and feedback:

BiotechTV U:

Info@BiotechTV.com

Universities@BiotechTV.com

Amy Brown

United Kingdom Area

Chris Garabedian

BioVenture VoiCes

Brad Loncar

Founder

Join our mail list

Disclosures & Policies